Keynote Speakers 2024

  • Prof. Dr. med Ana Guerreiro Stücklin, MD PhD

    Prof. Dr. med Ana Guerreiro Stücklin, MD PhD

    Oncology, University Children's Hospital Zurich

    Read more about Prof. Ana Guerreiro Stücklin’s research here:
    https://www.kispi.uzh.ch/kinderspital/person/guerreiro-stuecklin-md-phd-ana

  • Prof. Dr. Mitchell Levesque, PhD

    Prof. Dr. Mitchell Levesque, PhD

    Department of Dermatology, University Hospital Zurich

  • Prof. Dr. med. Chantal Pauli

    Prof. Dr. med. Chantal Pauli

    Department of Pathology and Molecular Pathology, University Hospital Zurich

  • Dr. med. Dr. sc. nat. Tobias Weiss

    Dr. med. Dr. sc. nat. Tobias Weiss

    Department of Neurology, University Hospital Zurich

    Read more about Dr. med. Dr. sc. nat. Tobias Weiss' research here:
    https://www.usz.ch/fachbereich/neurologie/forschung/neuro-onkologie/

  • Dr. med. vet Manuel Valiente, PhD

    Dr. med. vet Manuel Valiente, PhD

    CNIO - Centro Nacional de Investigaciones Oncológicas

    Read more about Dr. Valiente's research here:
    https://valientelab.com/

    Manuel Valiente is the Head of the Brain Metastasis Group at CNIO (2015-present). He investigates the biology of brain metastasis in order to challenge this unmet clinical need using his background in Neuroscience (PhD, Instituto de Neurociencias, 2005-2009) and Cancer Biology (Postdoc, MSKCC, 2010-2014).
    Specifically, his laboratory studies novel brain metastasis mediators, characterizes the metastasis-associated microenvironment, designs better experimental models and explores novel methods to target brain metastasis, including the frequent impact on
    brain activity. All these aims consider the brain environment as a critical component to understand the biology of this progression of cancer.
    Dr. Valiente has co-founded the first National Network of Brain Metastasis (RENACER) in Spain, which is allowing his team to speed up the translation of laboratory findings to the clinic. His contributions to brain metastasis research have been recognized with the Banco Sabadell Award, ASPIRE Award, ERC CoG, EMBO YIP, CLIP Award, Beug Foundation’s Prize for Metastasis Research, Bristol-Myers Squibb-MRA Young Investigator Award among others.
    He is the Chair of the Scientific Committee of the European Association of Neuro-Oncology (EANO), Board Member of the Metastasis Research Society (MRS) and ESMO faculty member (CNS Tumours faculty group).

Sponsors of the retreat in 2024

  • University of Zurich
  • ETH Zürich
Powered by Fourwaves